'Bribery', 'conflict of interest' plaguing FDA, says Senator Tulfo citing 'sources' | Inquirer News

‘Bribery’, ‘conflict of interest’ plaguing FDA, says Senator Tulfo citing ‘sources’

By: - Reporter / @DYGalvezINQ
/ 05:36 PM October 03, 2022
"Bribery" and "conflict of interest in the FDA are allegedly ongoing, according to Senator Tulfo.

FILE PHOTO: Facade of FDA office.

MANILA, Philippines — Senator Raffy Tulfo on Monday alleged that the Food and Drug Administration (FDA) is experiencing chronic bribery episodes and that an FDA officer appears to be in a conflict of interest.

During a hearing of the Senate finance committee on the 2023 budget of the Department of Health (DOH), Tulfo said his “sources” told him that bribes are involved in the registration of products. He also said that the buy-off ranges from P5 million to P10 million per product registration.

ADVERTISEMENT

He likewise mentioned that former FDA director general Sherry Puno admitted to him that corruption exists in the registration of products and that there was an attempt to cleanse the agency.

“She [Puno] admitted to me na talagang may nangyayaring gano’n, at nililinis daw ‘yung ganoong klaseng katiwalian sa FDA. Pero later on, siya po ay nasibak. Noong nawala siya, tuloy-tuloy pa rin ‘yung katiwalian – P5 million kung minsan mayroon pang P10 million na hinihingi per registration per product,” Tulfo said, addressing incumbent FDA chief Samuel Zacate.

FEATURED STORIES

(Puno admitted to me that there are incidents of bribery in the FDA, and the agency is already taking steps to address the problem. However, later on, she was sacked. Corruption persisted after she left; P5 million, occasionally P10 million, was demanded for the registration of each product.)

“‘Yan dapat talaga imbestigahan ninyo (You should really investigate that),” he added.

Conflict of interest

Tulfo also told the FDA chief to investigate the alleged conflict of interest on the agency’s director for cosmetics and household urban hazardous substances regulation and research, Ana Trinidad Rivera.

The senator claimed Rivera has a sibling working for a big pharmaceutical firm in the country, suggesting that the director be relocated to another post.

“Did you know na mayroon siyang kapatid na nagtatrabaho sa Zuellig? That’s conflict of interest kung totoo, pero kung sasabihin mong hindi, then mapapahiya ka. Siguro po i-transfer ninyo ito sa ibang location,” Tulfo said.

(Did you know she has a sibling working in Zuellig? Of course, that’s a conflict of interest if true, but if you’ll tell me that it’s not true, you will be ashamed.)

“Kung mayroon, bigyan ninyo siya ng ibang pwesto, siguro po sa janitorial services baka dun siya bagay para maglinis-linis po,” he added.

ADVERTISEMENT

(If there’s one, you should give her a new position, maybe in janitorial services maybe she fits there to clean up.)

For DOH officer-in-charge Maria Rosario Vergeire, the FDA and Civil Service Commission have rules for conflict of interest. However, she said she does not know what type of conflict of interest exists between Rivera and Zuellig.

FDA chief Zacate assured the senators that he would investigate the bribery and conflict of interest issues. However, he pointed out that the designation of FDA directors is lodged with the DOH secretary.

Senator Pia Cayetano, who was presiding over the DOH budget hearing, asked the agencies to submit information on its rules on conflict of interest.

She also suggested that a lifestyle check among the FDA’s officials and personnel be conducted.

RELATED STORY

Duterte fires FDA chief Nela Charade Puno over alleged corruption

KGA/abc
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: bribery, FDA, Raffy Tulfo
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.